This article is an editorial. My advice to you about COVID-19 vaccines, mutant strains, and “viral” therapies — along with action items to help you survive this pandemic.

In this and the next article I will discuss the various therapy options presently available to us, should you get infected with COVID-19 in spite of your best efforts.

Most often, CLL is slow moving beast.  But sometimes it creates problems that need quick action on your part.  Being able to spot an emergency and respond to it in real time may save your life.  Blood clots can cause strokes, heart attacks, even death. You are at risk and here is your wake-up call.

I think all of us can agree, getting a second cancer while we are trying to deal with the first one is a real bummer.  When the second cancer is caused by the drugs being used to treat your CLL, that is like adding insult to injury.

Cancer patients are often at risk of neutropenia (too few neutrophils) and growth factor drugs such as Neupogen and Neulasta are popular.  While they are important drugs and save  lives of many cancer patients, are there downside risks of their use that need to be better understood.

Statins are probably the most often prescribed medications in the world, for the purpose of lowering high cholesterol. Are statins good for cancer patients?As the title suggests, this is a controversial issue.  You can make up your own mind after reading the latest information on this subject.

Rituxan is part of most chemo combinations. Some protocols use Rituxan maintenance therapy as a way of prolonging remissions.  You should also be aware of the downside risks of this approach.

How accurately do adverse effects reported in journal articles reflect the reality of what average patients experience?  How are these statistics collected anyway?  Read on, I think you will be surprised.

A small percentage of CLL patients develop myelodysplastic syndrome (myeloid cancer precursor) and some of these guys go on to develop full fledged myeloid cancer. In this article we discuss risk factors and chemotherapy drugs that may increase your chances of myelodysplasia.

Cancer drugs are almost never cheap and the new fangled monoclonal antibodies are at the top of the money pyramid.  But we tend to focus on the cost of the actual drugs, rarely on the downstream cost of taking care of inevitable adverse effects associated with the drugs we use.